Pilot study of the [18F]THK-5351 positron emission tomography (PET) tracer in different tauopathies.

Next Previous
Trial Profile

Pilot study of the [18F]THK-5351 positron emission tomography (PET) tracer in different tauopathies.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Fluorine 18 THK 5351 (Primary)
  • Indications Tauopathies
  • Focus Diagnostic use

    • Most Recent Events

    • 13 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top